Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
21.11
+0.60 (2.93%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,767,283
Profits / Employee
$2,246,767
Market Cap
1.56B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Xencor | 260 |
| Maze Therapeutics | 141 |
| Absci | 140 |
| MoonLake Immunotherapeutics | 130 |
| AnaptysBio | 104 |
INVA News
- 1 day ago - Innoviva reports Q2 EPS ($1.14), consensus 49c - TheFly
- 1 day ago - Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress - Business Wire
- 1 day ago - Innoviva Quarterly report: Q2 2026 - Filings
- 1 day ago - Innoviva Earnings release: Q2 2026 - Filings
- 7 weeks ago - Innoviva’s Nortiva Bio launches to develop long-acting oral medicines - TheFly
- 7 weeks ago - Nortiva Bio Launches to Develop Long-Acting Oral Medicines - Business Wire
- 7 weeks ago - Innoviva announces distribution, licensing agreement with Dr. Reddy’s - TheFly
- 7 weeks ago - Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Markets - Business Wire